Conference Coverage
-
Conference Coverage
Spinal cord atrophy found to be accelerated in subset of RRMS patients
DALLAS – The finding marks the first of its kind.
-
Conference Coverage
Intensive blood pressure lowering may not reduce risk of recurrent stroke
HONOLULU – Intensive treatment significantly reduces blood pressure, compared with standard treatment, and is...
-
Conference Coverage
Telerehabilitation is noninferior to in-clinic rehabilitation for poststroke arm function
HONOLULU – Participants in both study groups had significant gains in arm function and stroke knowledge at 30 days...
-
Conference Coverage
Expert calls for more ‘ethnocentric’ research in MS
DALLAS – Understanding the effect of race/ethnicity is crucial to understanding MS disparities.
-
Conference Coverage
MS researchers aim to build MRI diagnostic portfolio beyond the central vein sign
DALLAS – Evaluation of lesion morphology is one emerging technology, according to Dr. Andrew J. Solomon.
-
Conference Coverage
Cerebellar volume may predict disability in patients with relapsing-remitting MS
DALLAS – Baseline cerebellar gray matter volume was the only MRI metric that significantly predicted 25-foot walk test results at 36 months.
-
Conference Coverage
A blood biomarker for MS: Coming to clinics soon?
DALLAS – Neurologists have lacked ways to monitor subclinical MS, but new developments suggest that blood levels of neurofilament light chain (NfL...
Latest News
-
From the Journals
Surge of gabapentinoids for pain lacks supporting evidence
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
-
Latest News
Trofinetide may benefit patients with Rett syndrome
Data from a phase 2 study expand on previous findings and suggest that trofinetide can alleviate core symptoms of the neurodevelopmental disorder...
-
From the Journals
Valproate, topiramate prescribed in young women despite known teratogenicity risks
These findings suggest a lack of awareness of the teratogenic risks of valproate and topiramate on the part of physicians and patients.
-
From the Journals
Rituximab does not improve fatigue symptoms of ME/CFS
Results from the phase 3 RituxME trial found no difference in fatigue score symptoms after 24 months.
-
From the Journals
Symptomatic former NFL players may have tau deposition consistent with CTE
Tau deposition is focused in brain regions affected by CTE, but may not be associated with cognitive or neuropsychiatric symptoms.
-
Latest News
Postvaccination febrile seizures are no more severe than other febrile seizures
Vaccine-proximate febrile seizures accounted only for a small proportion of febrile seizures in the study.
Literature Review
-
Literature Review
Many EMS protocols for status epilepticus do not follow evidence-based guidelines
Emergency medical services (EMS) system protocols vary in how they define and treat generalized convulsive status epilepticus, according to a...
-
Literature Review
Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients
Results from IDEAS, a prospective imaging study, refined Alzheimer’s disease diagnoses in both amyloid-positive and amyloid-negative cases. Now it...
-
Literature Review
Polyglutamine diseases are rare, but not the mutations that cause them
A population-based study found more than 10% of European adults carried CAG repeats in the pathogenic range, despite lacking signs of disease.
-
Literature Review
BACE-1 inhibition worsens cognition in patients with prodromal Alzheimer’s disease
Inhibiting the APP-cleaving enzyme decreased the toxic amyloid species, but it also worsened cognition and caused a variety of concerning adverse...
-
Literature Review
Low LDL cholesterol may increase women’s risk of hemorrhagic stroke
Investigators found no association between HDL cholesterol and risk of hemorrhagic stroke or between total cholesterol and risk of hemorrhagic...